These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 6169787)
1. Further studies on anti-tumor activity of adenovirus fibre protein on murine sarcoma tumours. Khoobyarian N J Gen Virol; 1981 Feb; 52(Pt 2):377-80. PubMed ID: 6169787 [TBL] [Abstract][Full Text] [Related]
2. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone. Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of murine sarcoma virus induced transformation by adenovirus structural proteins. Abid SH; Khoobyarian N J Gen Virol; 1976 Jun; 31(3):437-40. PubMed ID: 180250 [TBL] [Abstract][Full Text] [Related]
4. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis. Basombrío MA; Mayer AM; Pasqualini CD Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of murine sarcoma virus induced transformation in an adenovirus -- NRK system. Bourne KA; Major EO; Khoobyarian N In Vitro; 1979 Sep; 15(9):664-8. PubMed ID: 231569 [TBL] [Abstract][Full Text] [Related]
8. Effects of anti-interferon serum on growth and regression of Moloney sarcoma virus induced tumours in mice. Inglot AD; Oleszak E; Inglot O Acta Biol Med Ger; 1979; 38(5-6):829-35. PubMed ID: 525154 [TBL] [Abstract][Full Text] [Related]
9. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen. Powell TJ; Spann R; Nguyenduc M; Lamon EW J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772 [TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors. Gorczynski RM; Knight RA Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221 [TBL] [Abstract][Full Text] [Related]
11. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines. Robey WG; Kuenzel WJ; Vande Woude GF; Fischinger PJ Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443 [TBL] [Abstract][Full Text] [Related]
12. Antitumour activity of adenovirus-12 structural proteins against Moloney sarcoma tumours in mice. Abid SH; Khoobyarian N Br J Cancer; 1976 Apr; 33(4):385-91. PubMed ID: 1268030 [TBL] [Abstract][Full Text] [Related]
14. Prevention of murine sarcoma virus oncogenesis in offspring of immunized female mice. Chieco-Bianchi L; Collavo D; Biasi G; Colombatti A Br J Cancer; 1973 Sep; 28(3):238-44. PubMed ID: 4795530 [TBL] [Abstract][Full Text] [Related]
15. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
16. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus. Wood GW Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500 [TBL] [Abstract][Full Text] [Related]
17. Interferon effect on collagen and fibronectin distribution in the extracellular matrix of murine sarcoma virus-transformed cells. Gerfaux J; Rousset S; Chany-Fournier F; Chany C Cancer Res; 1981 Sep; 41(9 Pt 1):3629-34. PubMed ID: 6167350 [TBL] [Abstract][Full Text] [Related]
18. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792 [TBL] [Abstract][Full Text] [Related]
19. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge. Bateman WJ; Jenkinson EJ; Owen JJ Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180 [TBL] [Abstract][Full Text] [Related]
20. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Mayr GA; Chinsangaram J; Grubman MJ Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]